OLFML3
Basic information
Region (hg38): 1:113979391-114035572
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the OLFML3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 25 | 25 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 25 | 0 | 2 |
Variants in OLFML3
This is a list of pathogenic ClinVar variants found in the OLFML3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-113979530-C-G | not specified | Uncertain significance (Mar 28, 2024) | ||
1-113979530-C-T | not specified | Uncertain significance (Oct 17, 2023) | ||
1-113979575-A-G | not specified | Uncertain significance (Feb 06, 2024) | ||
1-113980365-C-T | not specified | Uncertain significance (Mar 18, 2024) | ||
1-113980384-G-T | not specified | Uncertain significance (Dec 22, 2023) | ||
1-113980410-C-G | not specified | Uncertain significance (Jan 27, 2022) | ||
1-113980418-G-C | not specified | Uncertain significance (Oct 03, 2022) | ||
1-113980482-C-T | not specified | Uncertain significance (Dec 26, 2023) | ||
1-113980492-G-A | not specified | Uncertain significance (Jan 16, 2024) | ||
1-113980498-T-C | not specified | Uncertain significance (Dec 14, 2023) | ||
1-113980504-A-G | not specified | Uncertain significance (Apr 07, 2023) | ||
1-113980612-T-C | not specified | Uncertain significance (Dec 13, 2021) | ||
1-113980950-C-G | Malignant tumor of prostate | Uncertain significance (-) | ||
1-113980960-A-C | not specified | Uncertain significance (Jun 11, 2024) | ||
1-113980963-A-G | not specified | Uncertain significance (Dec 16, 2023) | ||
1-113981108-G-A | not specified | Uncertain significance (Dec 19, 2023) | ||
1-113981133-C-A | EBV-positive nodal T- and NK-cell lymphoma | Likely benign (-) | ||
1-113981134-C-G | not specified | Uncertain significance (Jul 05, 2022) | ||
1-113981134-C-T | not specified | Uncertain significance (May 02, 2023) | ||
1-113981191-T-G | not specified | Uncertain significance (Aug 12, 2022) | ||
1-113981216-G-A | not specified | Uncertain significance (Jan 22, 2024) | ||
1-113981294-G-C | not specified | Uncertain significance (Jun 01, 2023) | ||
1-113981341-C-G | not specified | Uncertain significance (Jan 04, 2024) | ||
1-113981416-C-T | not specified | Uncertain significance (Aug 18, 2023) | ||
1-113981477-A-G | not specified | Uncertain significance (Oct 03, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
OLFML3 | protein_coding | protein_coding | ENST00000320334 | 3 | 2814 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
5.62e-8 | 0.423 | 125675 | 0 | 73 | 125748 | 0.000290 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.190 | 235 | 243 | 0.966 | 0.0000141 | 2597 |
Missense in Polyphen | 84 | 94.827 | 0.88582 | 975 | ||
Synonymous | 1.31 | 76 | 92.0 | 0.826 | 0.00000462 | 864 |
Loss of Function | 0.805 | 13 | 16.5 | 0.786 | 0.00000104 | 169 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000177 | 0.000177 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000872 | 0.000870 |
Finnish | 0.0000950 | 0.0000924 |
European (Non-Finnish) | 0.000276 | 0.000273 |
Middle Eastern | 0.000872 | 0.000870 |
South Asian | 0.000538 | 0.000523 |
Other | 0.000497 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Secreted scaffold protein that plays an essential role in dorsoventral patterning during early development. Stabilizes axial formation by restricting chordin (CHRD) activity on the dorsal side. Acts by facilitating the association between the tolloid proteases and their substrate chordin (CHRD), leading to enhance chordin (CHRD) degradation (By similarity). May have matrix-related function involved in placental and embryonic development, or play a similar role in other physiological processes. {ECO:0000250, ECO:0000269|PubMed:15280020}.;
Recessive Scores
- pRec
- 0.110
Intolerance Scores
- loftool
- 0.321
- rvis_EVS
- 0.06
- rvis_percentile_EVS
- 58.85
Haploinsufficiency Scores
- pHI
- 0.669
- hipred
- N
- hipred_score
- 0.282
- ghis
- 0.559
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.966
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Olfml3
- Phenotype
- normal phenotype;
Gene ontology
- Biological process
- multicellular organism development
- Cellular component
- extracellular vesicle
- Molecular function